Ignite Creation Date:
2024-05-06 @ 4:15 PM
Last Modification Date:
2024-10-26 @ 2:06 PM
Study NCT ID:
NCT04922788
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-11-04
First Post:
2021-06-08
Brief Title:
Study to Evaluate the Safety Immunogenicity and Efficacy of Nanocovax Vaccine Against COVID-19
Sponsor:
Nanogen Pharmaceutical Biotechnology Joint Stock Company
Organization:
Nanogen Pharmaceutical Biotechnology Joint Stock Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-07
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-12-07
Completion Date Type:
ESTIMATED
First Submit Date:
2021-06-08
First Submit QC Date:
June 10 2021
Study First Post Date:
2021-06-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-03
Last Update Post Date:
2022-11-04
Last Update Post Date Type:
ACTUAL